European Space Agency   Report issue

Academic/Hospital Phase 1
Founded: Paris France (1975)

Organization Overview

First Clinical Trial
2001
NCT00311571
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

European Space Agency

Indications

Overview

  • Highest Phase: Phase 1
  • # of Trials: 5
  • # of Trial APIs: 8